SABPA第14届太平洋论坛暨第7届太平洋生物技术合作峰会将于9月29日召开

SABPA第14届太平洋论坛暨第7届太平洋生物技术合作峰会将于2018年9月29日在美国南加州圣地亚哥召开。

14th Annual SABPA Pacific Forum and 7th SABPA Bio-Partnering

WHEN September 29, 2018 @ 8:00am – 5:00pm
WHERE Hilton San Diego/Del Mar 15575 Jimmy Durante Blvd, Del Mar, CA
INFO Parking is free, Cocktail hour open to all attendees On-site registration available.
REGISTER

Join SABPA LinkedIn Group at https://www.linkedin.com/groups/118216 by September 25th and receive $15 discount (discount code will be emailed to you within 24 hours after approval, click here for more details).

Pacific Forum: Register here

Biopartnering: Register here

14th Annual SABPA Pacific Forum

The annual SABPA Pacific Forum has become an important platform to showcase the latest developments in biotech/pharmaceutical industry across the Pacific. Come and meet industry leaders and hear about the increasing integration of drug research and development around the globe, rapid changes in government regulations, and opening-up of the Chinese pharmaceutical market. Register now to learn how to seize these new opportunities.

Confirmed speakers:

Joel Day, Director, Department of Boards and Commissions at City of San Diego

Kathleen Charla, Vice Chair, International Affairs Board City of San Diego

Changjin Wang, CEO, Frontier Biotechnology

Yuan Xu, CEO, Legend Biotech

Sheng Ding, Professor, Dean/Institute Director, Tsinghua Univ./GHDDI

Brent Johnson, Patent Attorney, Maschoff Brennan

 

 

Nancy Chang,  CEO and PresidentApex Enterprises

Fan Zhang,  PhD, Pre-POC Clinical Assets and Cancer Vaccines Lead, Pfizer

Min Guo, PhD, President and COO, Ascentage Pharma

Bin Li, PhD, Founder & Chief Investment Officer, Ally Bridge LB Healthcare Fund

Katherine Atkinson, COO, Epic Sciences

Michael Haller, PhD, CFO, Denovo BioPharma

Jing Zhangm PhD, Senior Engineer, Business Development manager, Shanghai Pharma

Alan Seem, JD, Partner, Jones Day

Panel discussion:

  • Driving forces behind the boom of China’s life science industry

Confirmed panelists:

Ming Guo, PhD, President and COO, Ascentage Pharma

Michael Haller, PhD, CFO, Denovo BioPharma

Bin Li, PhD, Founder & Chief Investment Officer, Ally Bridge LB Healthcare Fund

Alan Seem, JD, Partner, Jones Day

 

Panel discussion:

  • Driving forces behind the boom of China’s life science industry

Confirmed panelists:

Ming Guo, PhD, President and COO, Ascentage Pharma

Michael Haller, PhD, CFO, Denovo BioPharma

Bin Li, PhD, Founder & Chief Investment Officer, Ally Bridge LB Healthcare Fund

Alan Seem, JD, Partner, Jones Day

Registration:

$45 for general admission ($80 onsite)

$30 for postdoc/students ($60 onsite)

$100 1-on-1 Biopartnering with complimentary general admission (registration closes on September 25th, 2018)

7th SABPA Bio-PartneringParalleled with Pacific Forum, Hilton Del Mar, Sept. 29, 2018

Co-Organizers: SABPA, ChinaBio

SABPA Bio-Partnering is a great platform to explore opportunities in licensing, investment, fund raising and other collaboration deals.  It is designed for you to pre-arrange 1-on-1 face-to-face meetings with potential partners/investors/entrepreneurs by using the EBD online tool Partnering360*.  Participants can upload their profile to the platform, and send invitations to other participants.   Once the invitations are accepted, the 30 min private meetings will be arranged automatically.   Participants will have access to pre-scheduled 1-on-1 meetings in designated meeting areas during the conference, as well as access to Partnering360 database all year round.   Bio-Partnering will be hosted at the same time and venue with SABPA Pacific Forum (09/29/2018).  Please check the link below for more details.

http://www.sabpa.org

Who shall attend?

  • Entrepreneurs and executives from local biotech and pharmaceutical companies
  • Chinese pharmaceutical companies who are looking for collaboration opportunities
  • Investors from local firms and across Pacific
  • Biotech or pharmaceutical service providers

Current and Previous Participating Organizations

Current and Previous Participating Organizations
Investors
  • GF-Bay City Capital Int. Life Sciences USD Fund
  • Qiming US Healthcare Venture Fund
  • Illumina Ventures   
  • C-Bridge Capital
  • Ally Bridge Group
  • HuaQi Capital
  • Proxima Ventures
  • Venus Capital Fund
Companies
  • Abbvie
  • Eli Lilly
  • Johnson & Johnson Innovation
  • Shanghai Pharma
  • Fosun Pharma
  • Kelun Pharma  
  • CTTQ Pharma
  • Simcere
  • Livzon
  • Denovo Biopharma
Incubators
  • China Medical City (CMC)
  • Zhongshan Healthcare Technology Park
  • Sino-Singapore (Chengdu) Innovation Park
  • Songshan Lake
  • TEDA
  • HEDA

How to Participate?

  • Register for SABPA Bio-Partnering event and SABPA Pacific Forum at the link below:

 https://whova.com/portal/registration/thsab_201809

($100, online only, includes: SABPA Pacific Forum, dinner, parking)

  • Receive a private Partnering360 log-in link sent by Whova after your registration
  • Access Partnering360 to setup your profile and schedule meetings. Step-by-step instruction is available here:  http://www.sabpa.org/1on1instruction2017/
  • Please act early to allow time for meeting arrangement (> 2 weeks prior to the event date)

Need Help? Please email: bio1on1@sabpa.org


How to Participate?

  • Register SABPA Bio-Partnering event and SABPA Pacific Forum at the link below:

http://www.sabpa.org/registration-2

($100, online only, complimentary admission to SABPA Pacific Forum included)

  • Receive a private Partnering360 log-in link sent by Whova after your registration
  • Access Partnering360 to setup your profile and schedule meetings. Step-by-step instruction is available here:  http://www.sabpa.org/1on1instruction2017/
  • Please act early to allow time for meeting arrangement (> 2 weeks prior to the event date)

 

Need Help? Please email: bio1on1@sabpa.org